Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls (Q37315523)

19 August 2017

1 reference

title

Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls (English)

1 reference

19 August 2017

1 reference

1 reference

2

1 reference

19 August 2017

Siobhan O'Donnell

1

1 reference

19 August 2017

Kelli Thomas

series ordinal

3

1 reference

19 August 2017

David A Hanley

series ordinal

4

1 reference

19 August 2017

Ann Cranney

series ordinal

5

1 reference

19 August 2017

language of work or name

1 reference

1 November 2008

1 reference

Journal of Bone and Mineral Metabolism

19 August 2017

1 reference

19 August 2017

26

1 reference

19 August 2017

531-542

1 reference

19 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00774-008-0868-y

19 August 2017

0 references

cites work

The role of the vitamin D endocrine system in health and disease

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0868-Y

Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0868-Y

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0868-Y

Calcitriol treatment is not effective in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0868-Y

Better reporting of harms in randomized trials: an extension of the CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0868-Y

Early postmenopausal bone loss is prevented by estrogen and partially by 1alpha-OH-vitamin D3: therapeutic effects of estrogen and/or 1alpha-OH-vitamin D3

21 January 2018

1 reference

12 December 2020

Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss

1 reference

12 December 2020

Quantifying heterogeneity in a meta-analysis

1 reference

12 December 2020

The D-hormone analog alfacalcidol: the pioneer beyond the horizon of osteoporosis treatment.

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study

1 reference

12 December 2020

Calcitriol in the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group

1 reference

12 December 2020

Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology

1 reference

12 December 2020

BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

1 reference

12 December 2020

Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis

1 reference

12 December 2020

Do all hip fractures result from a fall?

1 reference

12 December 2020

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

12 December 2020

Benefits and requirements of vitamin D for optimal health: a review.

1 reference

12 December 2020

Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews.

1 reference

12 December 2020

Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study

1 reference

12 December 2020

Alfacalcidol (alpha D3) and calcium in osteoporosis

1 reference

12 December 2020

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

12 December 2020

The statistical basis of meta-analysis

1 reference

12 December 2020

Effects of 2 years' treatment of osteoporosis with 1 alpha-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study

1 reference

12 December 2020

Risk of Mortality Following Clinical Fractures

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis with calcitriol or calcium

1 reference

12 December 2020

Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study

1 reference

12 December 2020

The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures.

1 reference

12 December 2020

Impact of hip and vertebral fractures on quality-adjusted life years.

1 reference

12 December 2020

The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency

1 reference

12 December 2020

An estimate of the worldwide prevalence, mortality and disability associated with hip fracture

1 reference

12 December 2020

Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis

1 reference

12 December 2020

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

1 reference

12 December 2020

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

12 December 2020

Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis

1 reference

12 December 2020

Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily

1 reference

12 December 2020

A comprehensive review of treatments for postmenopausal osteoporosis

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women

1 reference

12 December 2020

Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: a systematic review

1 reference

12 December 2020

Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis

1 reference

12 December 2020

Osteoporosis prevention, diagnosis, and therapy

1 reference

12 December 2020

Elevated PTH levels in hypovitaminosis D are more rapidly suppressed by the administration of 1,25-dihydroxy-vitamin D3 than by vitamin D3

1 reference

12 December 2020

Comparison of methods for defining prevalent vertebral deformities: the Study of Osteoporotic Fractures.

1 reference

12 December 2020

Effects of the combined use of calcitonin and 1 alpha-hydroxycholecalciferol on vertebral bone loss and bone turnover in women with postmenopausal osteopenia and osteoporosis: a prospective study of long-term and continuous administration with low d

1 reference

12 December 2020

Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis

1 reference

12 December 2020

Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate

1 reference

12 December 2020

Calcium supplementation on bone loss in postmenopausal women

1 reference

12 December 2020

Effect of Vitamin D on falls: a meta-analysis

1 reference

12 December 2020

10.1007/S00774-008-0868-Y

Identifiers

DOI

1 reference

19 August 2017

1 reference